Targeted Services | Targeted Bioscience

Targeted Services and Advanced Diagnostics Testing

Accurate, high-complexity clinical trial testing and research services in collaboration with George Mason University's CAP/CLIA-certified laboratories.

We accelerate the path from research to patient care.

Cutting-Edge Clinical Diagnostics Backed by George Mason University

At Targeted Bioscience, we are proud to partner with George Mason University's CAP/CLIA-certified Clinical Diagnostics Laboratory (GMCDL) and Clinical Proteomics Laboratory (CPL). Our mission is to bring advanced medical technologies to clinical practice, focusing on personalized medicine and innovative diagnostic solutions.

Innovative Technologies for Rigorous Testing and Validation

Our lab is equipped to provide comprehensive diagnostic services, leveraging advanced proteomic mass spectrometry, RT-PCR diagnostics, and spatial tissue imaging technologies. We excel in the verification of biomarkers and the development of customized test panels tailored to the unique needs of clinical trials.

Proteomics Mass Spectrometry

Equipped with cutting-edge instruments like the Bruker timsTOF and ThermoFisher Exploris 480.

RT-PCR Diagnostics

High-throughput testing capabilities, including digital PCR and SNP genotyping.

Spatial Tissue Imaging

State-of-the-art DakoCytomation Autostainers and PhenoCycler-Fusion technology for tissue profiling.

Next Generation Sequencing (NGS)

High-throughput sequencing technology, enabling precise genomic and transcriptomic profiling.

Laser Capture Microdissection (LCM)

Allows researchers to quickly and easily capture spatial biology insights and unlock unique molecular signatures down to single-cell level

Custom Assay and Biomarkers Solutions

Extensive capabilities in evaluating and verifying novel proteomic technologies and biomarkers, we accelerate the path from research to patient care

Extracellular Vesicles from the Living tissue microenvironment

Isolate and analyze EV's at their origin

Targeted Labs
Pro

Digital Pathology Solutions

Bringing Precision to Clinical Trials and Diagnostics

We have collaborated with leading institutions on a variety of critical projects, from cancer clinical trials to COVID-19 testing. Our contributions include:

Cancer Clinical Trials: Supported by partnerships with organizations such as Genentech and NIH.
COVID-19 Response: Over 250,000 PCR tests with a 24-hour turnaround.
Infectious & Neurological Disease Testing: Backed by Gates Foundation and VA funding.
Tissue Microenvironment Research: Advanced spatial profiling for cancer and other diseases.

Meet Our Experts: Bringing Decades of Experience to Advanced Diagnostics

Our team is led by some of the foremost experts in cancer research, clinical trial design, and proteomics. With extensive backgrounds in medical diagnostics, our leadership is dedicated to ensuring cutting-edge research is seamlessly integrated into our testing services.

Lance A. Liotta, MD PhD

MEDICAL DIRECTOR

Expertise in biomedical engineering, pathology, and cancer molecular profiling.

Virginia Espina, PhD

LABORATORY DIRECTOR

Specialist in cancer molecular biology and women’s health research.

Chip Petricoin, PhD

CO-DIRECTOR

Experienced in cancer signaling, FDA compliance, and clinical trial design.

Alessandra Luchini, PhD

PROFESSOR

Focused on advanced medical and infectious disease testing.

Partner with Us for Advanced Diagnostics

Whether you're conducting clinical trials or need custom test panels, Targeted Bioscience provides the advanced diagnostic services and expertise you need to ensure precision and reliability in your testing outcomes.